Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 64485-93-4 | Product Number: C2224
Cefotaxime Sodium Salt
Purity: >96.0%(HPLC)
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
| Product Number | C2224 |
Purity / Analysis Method
|
>96.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__1__6N__5NaO__7S__2 = 477.44 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Hygroscopic,Heat Sensitive |
| CAS RN | 64485-93-4 |
Related CAS RN
|
63527-52-6 |
| Reaxys Registry Number | 6564218 |
| PubChem Substance ID | 87560124 |
| SDBS (AIST Spectral DB) | 52166 |
| Merck Index (14) | 1933 |
| MDL Number | MFCD00079073 |
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 96.0 area% |
| Purity(Nonaqueous Titration) | min. 96.0 % |
| Specific rotation [a]20/D | +58.0 to +64.0 deg(C=1, H2O)(calcd.on dried substance) |
| Drying loss | max. 3.0 % |
| NMR | confirm to structure |
| Melting Point | 163 °C(dec.) |
| Specific Rotation | 61° (C=1,H2O) |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary Statements | P261 : Avoid breathing dust. P280 : Wear protective gloves. P284 : Wear respiratory protection. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P304 + P340 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. |
| EC Number | 264-915-9 |
| RTECS# | XI0250000 |
| HS Number | 2941900000 |
References
- Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity
- Cefotaxime (an overview)
- Drug utilization review (DUR) of the third generation cephalosporins: Focus on ceftriaxone, ceftazidime and cefotaxime
- Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review
- Cefotaxime sodium: A new and efficient corrosion inhibitor for mild steel in hydrochloric acid solution
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.